28 Pa. Code § 715.14 - Urine testing
(a) A narcotic
treatment program shall complete an initial drug-screening urinalysis for each
prospective patient and a random urinalysis at least monthly thereafter.
(1) Each test shall be for opiates,
methadone, amphetamines, barbiturates, cocaine and benzodiazepines.
(2) If the narcotic treatment program
determines that other drugs are abused in that narcotic treatment program's
locality or have been identified in the patient's drug and alcohol history as
being a drug of abuse or use, a narcotic treatment program may conduct a test
or analysis for other drugs as well.
(b) A narcotic treatment program shall
develop and implement policies and procedures to ensure that urine collected
from patients is unadulterated. These policies and procedures shall include
random observation which shall be conducted professionally, ethically and in a
manner which respects patient privacy.
(c) A narcotic treatment program shall
develop and implement policies and procedures to minimize misidentification of
urine specimens and to ensure that the tested specimens can be traced to the
donor.
(d) A narcotic treatment
program shall ensure that a laboratory that performs the testing required under
this section shall be in compliance with applicable Federal requirements,
specifically the Clinical Laboratory Improvement Amendments of 1998
(42 U.S.C.A. §§
201 note, 263 and 263a notes), and State
requirements, specifically the Pennsylvania Clinical Laboratory Act
(35
P. S. §§
2151-2165) and Chapter 5
(relating to clinical laboratories).
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.